Cargando…

Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease

Rheumatic heart disease (RHD) affects numerous individuals annually; however, its pathogenesis remains unclear. The sphingosine 1-phosphate receptor 1 (S1PR1) and signal transducer and activator of transcription 3 (STAT3) have recently been shown to be involved in valvular damage via the promotion o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xian, Shenglin, Chen, Ang, Wu, Yunjiao, Wen, Hong, Lu, Chuanghong, Huang, Feng, Zeng, Zhiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354313/ https://www.ncbi.nlm.nih.gov/pubmed/34296288 http://dx.doi.org/10.3892/ijmm.2021.5012

Ejemplares similares

Inhibition of miR-155-5p attenuates the valvular damage induced by rheumatic heart disease
por: Chen, Ang, et al.
Publicado: (2020)

Activation of activin/Smad2 and 3 signaling pathway and the potential involvement of endothelial-mesenchymal transition in the valvular damage due to rheumatic heart disease
por: Xian, Shenglin, et al.
Publicado: (2021)

Oridonin Attenuates Myocardial Ischemia/Reperfusion Injury via Downregulating Oxidative Stress and NLRP3 Inflammasome Pathway in Mice
por: Lu, Chuanghong, et al.
Publicado: (2020)

Signalling pathways implicated in the pathogenesis of rheumatic heart disease (Review)
por: Xian, Shenglin, et al.
Publicado: (2021)

Acute Rheumatism and Valvular Disease
Publicado: (1900)

Valvular Damage
por: Monte, Ines Paola, et al.
Publicado: (2020)

Coconut Atrium in Long-Standing Rheumatic Valvular Heart Disease
por: Onishi, Takahisa, et al.
Publicado: (2015)

Overexpression of Transforming Growth Factor-β1 in the Valvular Fibrosis of Chronic Rheumatic Heart Disease
por: Kim, Lucia, et al.
Publicado: (2008)

Interference of PR3-ANCA with the enzymatic activity of PR3
por: Rarok, AA, et al.
Publicado: (2002)

Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors
por: Lee, Heehyoung, et al.
Publicado: (2010)

PERSISTENCE OF STREPTOCOCCAL GROUP A ANTIBODY IN PATIENTS WITH RHEUMATIC VALVULAR DISEASE
por: Dudding, Burton A., et al.
Publicado: (1968)

Challenges in rheumatic valvular disease: Surgical strategies for mitral valve preservation
por: Antunes, Manuel J
Publicado: (2015)

Drug-Induced- or Rheumatic- Valvular Heart Disease in Patients Exposed to Benfluorex?
por: Le Ven, Florent, et al.
Publicado: (2016)

The value of urotensin II in patients with left-sided rheumatic valvular regurgitation
por: Elmadbouh, Ibrahim, et al.
Publicado: (2017)

Bilateral Secondary Femorocele in a Case of Ascites Due to Cardiac Cirrhosis Following Dual Valvular Replacement for Rheumatic Heart Disease
por: Vagholkar, Ketan
Publicado: (2023)

Clinical, Echocardiographic Characteristics and Management Practices in Patients with Rheumatic Valvular Heart Disease
por: Mulugeta, Temesgen, et al.
Publicado: (2020)

Improvement of Rheumatic Valvular Heart Disease in Patients Undergoing Prolonged Antibiotic Prophylaxis
por: Torres, Renato Pedro de Almeida, et al.
Publicado: (2021)

Transcatheter Valve-in-Valve Procedures for Bioprosthetic Valve Dysfunction in Patients With Rheumatic vs. Non-Rheumatic Valvular Heart Disease
por: Lopes, Mariana Pezzute, et al.
Publicado: (2021)

The effect of levosimendan on right ventricular function in patients with heart dysfunction: a systematic review and meta-analysis
por: Hu, Yaoshi, et al.
Publicado: (2021)

The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures
por: O’Sullivan, Catherine, et al.
Publicado: (2016)

Mitral valve sub valvular apparatus preservation in pure or predominant rheumatic mitral stenosis
por: Bouzid, Abdelmalek, et al.
Publicado: (2015)

Rheumatic valvular heart disease combined with woven coronary artery: a case report
por: Liu, Zhengjiang, et al.
Publicado: (2020)

Detecting sub-clinical disease activity in patients with chronic rheumatic valvular heart disease
por: Singal, Aayush Kumar, et al.
Publicado: (2021)

Hsa_circ_0000437 upregulates and promotes disease progression in rheumatic valvular heart disease
por: Zhu, Linwen, et al.
Publicado: (2021)

The COVID-19 Pandemic Surge and Impact on Rheumatic Valvular Heart Disease Patient Care
por: Kulkarni, Prashanth, et al.
Publicado: (2021)

Rheumatic valvular heart disease treated with traditional Chinese medicine: A case report
por: Chen, Wei-Hang, et al.
Publicado: (2023)

Prognostic value of clinical and Doppler echocardiographic findings in children and adolescents with significant rheumatic valvular disease
por: Araújo, Fátima Derlene da Rocha, et al.
Publicado: (2012)

Chronic Endo-Carditis, Independent of Rheumatism and Amenable to Treatment, Simulating Confirmed and Irremediable Valvular Disease
por: Bell, Benjamin
Publicado: (1877)

Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis
por: Jaiteh, Lamin E. S., et al.
Publicado: (2021)

Multiple left ventricular myxomas combined with severe rheumatic valvular lesions: A case report
por: Liu, Sheng-Zhong, et al.
Publicado: (2021)

GliPR1 knockdown by RNA interference exerts anti‐glioma effects in vitro and in vivo
por: Scheuring, Urban J., et al.
Publicado: (2021)

Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine
por: Lankadasari, Manendra Babu, et al.
Publicado: (2018)

Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death
por: Shang, Zeng-Fu, et al.
Publicado: (2016)

miR-150-Based RNA Interference Attenuates Tubulointerstitial Fibrosis through the SOCS1/JAK/STAT Pathway In Vivo and In Vitro
por: Luan, Junjun, et al.
Publicado: (2020)

Giant Right Atrium: An Extreme Structural Damage Case Due to Rheumatic Heart Disease
por: Voltarelli, Clara L, et al.
Publicado: (2023)

Tricuspid annular plane systolic excursion is correlated with poor outcome in surgery for rheumatic heart valvular disease
por: Khan, Imran, et al.
Publicado: (2019)

A Tailored Approach to the Ablation of Atrial Fibrillation in Rheumatic Valvular Disease with High-density Grid Technology
por: Rillo, Mariano, et al.
Publicado: (2021)

Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients
por: Rosa, Vitor Emer Egypto, et al.
Publicado: (2021)

Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling
por: Su, Zhongping, et al.
Publicado: (2020)

Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases
por: Scotece, Morena, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vcjrfdi5l7jb7l16utvkh7e1q2